Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_assertion type Assertion NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_head.
- NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_assertion description "[In both immortalized normal (TIOSE) and ovarian carcinoma cell lines (OVCA), SnoN RNA levels were increased by TGFbeta stimulation and altered by LY294002 and JNK II inhibitor treatment suggesting that the PI3K and JNK signaling pathways may regulate TGFbeta-induced increases in SnoN RNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_provenance.
- NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_assertion evidence source_evidence_literature NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_provenance.
- NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_assertion SIO_000772 19383336 NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_provenance.
- NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_assertion wasDerivedFrom befree-20150227 NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_provenance.
- NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_assertion wasGeneratedBy ECO_0000203 NP625439.RAbxSCQIvapgRxE9-JU_qLEgf3GI5MvBtle2_FMP15MKc130_provenance.